Chemoinformaics analysis of majoranin
Molecular Weight | 252.398 | nRot | 11 |
Heavy Atom Molecular Weight | 224.174 | nRig | 18 |
Exact Molecular Weight | 252.209 | nRing | 1 |
Solubility: LogS | -4.995 | nHRing | 0 |
Solubility: LogP | 5.916 | No. of Aliphatic Rings | 1 |
Acid Count | 1 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
Atoms Count | 46 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 18 | No. of Aromatic Carbocycles | 0 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 28 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 16 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
nHA | 1 | APOL | 46.9942 |
nHD | 1 | BPOL | 28.9578 |
QED | 0.448 |
Synth | 3.021 |
Natural Product Likeliness | 1.34 |
NR-PPAR-gamma | 0.036 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0.813 |
Pgp-sub | 0.017 |
HIA | 0.018 |
CACO-2 | -4.712 |
MDCK | 0.0000176 |
BBB | 0.006 |
PPB | 0.723357 |
VDSS | 1.018 |
FU | 0.1266 |
CYP1A2-inh | 0.968 |
CYP1A2-sub | 0.171 |
CYP2c19-inh | 0.945 |
CYP2c19-sub | 0.091 |
CYP2c9-inh | 0.891 |
CYP2c9-sub | 0.695 |
CYP2d6-inh | 0.555 |
CYP2d6-sub | 0.462 |
CYP3a4-inh | 0.553 |
CYP3a4-sub | 0.143 |
CL | 15.892 |
T12 | 0.118 |
hERG | 0.059 |
Ames | 0.334 |
ROA | 0.132 |
SkinSen | 0.263 |
Carcinogencity | 0.25 |
EI | 0.083 |
Respiratory | 0.617 |
NR-Aromatase | 0.842 |
Antiviral | Yes |
Prediction | 0.734172 |